Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis

Evolution of the healthcare expenditure in Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis

2016 GRHTA

Ruggeri, M. | Aiello, A. | D’Ausilio, A. | Di Brino, E. | Cottone, S. | Ghezzi, A. | Lombardozzi, L. | Mecozzi, A. | Sacchini, D. | Roccia, A. | Mangone, M. | Toumi, M. | Volume: 3, Issue: 3, Pages: 125–133,